International Clinical Trial: A prospective, multicenter, open-label, single-arm, Real World Evidence study with Masked IOP Assessment to evaluate efficacy(Effectiveness) of Netarsudil 0.02% ophthalmic solution as an Add-On therapy in patients with Normal-Tension Glaucoma receiving latanoprost 0.005%

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (KCT0012553) titled 'A prospective, multicenter, open-label, single-arm, Real World Evidence study with Masked IOP Assessment to evaluate efficacy(Effectiveness) of Netarsudil 0.02% ophthalmic solution as an Add-On therapy in patients with Normal-Tension Glaucoma receiving latanoprost 0.005%' on Sept. 3.

Study Type: Interventional Study

Study Design: Primary Purpose : Treatment, Intervention Model : Single Group, Blinding/Masking : Open, Allocation : Not Applicable

Primary Sponsor: Seoul National University Bundang Hospital

Condition:

Diseases of the eye and adnexa

Intervention: Drug : Subjects who were finally selected/excluded a...